, Volume 9, Issue 5, pp 325-328
Date: 29 Sep 2009

When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access